New cancer clinical trial: Circulating Tumour DNA as a Marker of Residual Disease & Response to Adjuvant Chemotherapy in Stage I-IV Ovarian Cancer

Published on: October 01, 2018 at 09:30PM

• Tweet
• Share
• Share
• Share
• Share